Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Clinical trial NCT02630316 · COMPLETED

Trial details

NCT number: NCT02630316
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension Interstitial Lung Disease Combined Pulmonary Fibrosis and Emphysema

Start date: 2017-02-03
Primary completion: 2019-12-26
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.